Anisha Rimal, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |
Dr. William Raszka, M.D. Pediatrics - Pediatric Infectious Diseases Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 Fax: 802-847-8742 |
Dr. Valerie J. Riss, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave., C/o Uvm Medical Center, Children's/pedi-hospitalists, Burlington, VT 05401 Phone: 802-847-2700 |
Dr. Nancy A Drucker, M.D. Pediatrics - Pediatric Cardiology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 Fax: 802-847-8742 |
Dr. Nilgun Tapucu Zimakas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4696 Fax: 902-847-4612 |
Dr. Joseph Francis Hagan Jr., M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 128 Lakeside Ave, Suite 115, Burlington, VT 05401 Phone: 802-860-1928 |
Dr. Elizabeth Duncan Ulano, MD Pediatrics - Pediatric Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave., Uvm Medical Center, Children's/picu, Burlington, VT 05401 Phone: 802-847-2304 Fax: 802-847-0258 |
Garrick A Applebee, M.D. Pediatrics - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: Uhc Campus, 1 South Prospect Street, Burlington, VT 05401 Phone: 802-847-5338 |
Dr. Jennifer Todd, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 |
Heidi Kristen Schumacher, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |
Dr. Matthew Colby Hollander, MD, MHA Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 |
Dr. Molly Moore, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 |
Michelle Tamara Shepard, M.D., PHD. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4696 |
Dr. Kelly Jean Cowan, M.D. Pediatrics - Pediatric Pulmonology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Burlington, VT 05401 Phone: 802-847-0000 |
Benjamin Lee, MD Pediatrics - Pediatric Infectious Diseases Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Uvm Medical Center, Pediatrics-infectious Disease, Burlington, VT 05401 Phone: 802-847-8200 |
Jillian Sarah Sullivan, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-3544 |
Dr. John W Wax, MD Pediatrics - Hospice and Palliative Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4848 Fax: 802-847-2929 |
Dr. Jessica L. Heath, MD Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Uvm Medical Center - Children's, Pedi-hem/onc, Burlington, VT 05401 Phone: 802-847-2850 Fax: 802-847-5557 |
Dr. Barry Finette, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-656-2296 Fax: 802-656-2077 |
Dr. Lewis R. First, M.D., M.S., FAAP Pediatrics Medicare: Medicare Enrolled Practice Location: Given Courtyard S 250, Burlington, VT 05405 Phone: 802-656-0027 Fax: 802-656-2077 |
News Archive
Express Scripts has launched a suite of services for pharmaceutical and biotech companies through HealthBridge Pharma & Biotech, providing a single-solution approach to patient care.
Genzyme, a Sanofi company, today announced that it has begun shipping Fabrazyme (agalsidase beta) produced at its newly approved plant in Framingham, Massachusetts. As previously communicated, patients in the U.S. are now able to return to full dosing in March. In addition, all new patients in the U.S. are eligible to begin Fabrazyme treatment, at full dosing levels.
A clinical trial of the glucose-control drug sitagliptin among patients with type 2 diabetes and established cardiovascular disease has found it did not raise the risk of major adverse cardiovascular events.
The recent report by the U.S. Centers for Disease Control and Prevention (CDC) published in JAMA Pediatrics, highlights the rising prevalence of prediabetes, which can lead to type 2 diabetes if it's not treated or controlled early. In the country, an estimated 18 percent among adolescents between the ages of 12 and 18, and 24 percent among young adults, between 19 and 34 have prediabetes.
› Verified 2 days ago